ChartRow logo
Share this page
TWST
$193.24+3.82%
as of close, Sep 30, 2026
☾ AH $193.24 +3.82%
Twist Bioscience CorporationStock · Health CareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.008%Russell 3000 0.008%
PeersMRNALLYUNHJNJMRKTMO

TWST financial statements

The full income statement, balance sheet, and cash-flow statement for Twist Bioscience Corporation (TWST), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 58.6M2024-09 59.4M2024-12 59.7M2025-03 59.9M2025-06 60.4M2025-09 61.1M2025-12 61.3M2026-03 62.3M2026-06 62.7M+7.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofSep 30 ’25as ofSep 30 ’24as ofSep 30 ’23as ofSep 30 ’22as ofSep 30 ’21
Revenue377M+20.3%313M+27.7%245M+20.4%204M+53.8%132M+46.9%
Cost of revenue186M+3.3%180M+15.6%155M+30.2%119M+48.0%80.6M+31.3%
Research & development80.3M-11.6%90.9M-15.0%107M-11.1%120M+74.2%69.1M+60.6%
Selling, general & administrative247M+13.1%218M+15.1%190M-10.9%213M+56.7%136M+31.6%
Amortization of intangibles1.10M-73.2%4.10M-22.6%5.30M+8.2%4.90M+880.0%500K+150.0%
Provision for credit losses———-11.0K-127.5%40.0K
Operating income-136M+38.3%-221M-1.7%-217M+7.5%-235M-53.7%-153M-9.0%
Interest expense—29.0K+480.0%5.00K-93.8%80.0K-78.2%367K-53.4%
Interest & investment income11.4M-25.9%15.3M+6.8%14.4M+369.1%3.06M+603.9%435K-71.0%
Other non-operating income-903K+66.3%-2.68M-298.7%-672K+38.2%-1.09M+20.7%-1.37M-652.7%
Pre-tax income-77.0M+63.0%-208M-2.3%-203M+10.9%-228M-48.2%-154M-10.4%
Income tax719K+28.4%560K-51.4%1.15M+111.1%-10.4M-439.4%-1.93M-605.2%
Net income-77.7M+62.8%-209M-2.0%-205M+6.1%-218M-43.2%-152M-8.7%
-$1.30+63.9%-$3.60+0.0%-$3.60+10.9%-$4.04-28.3%-$3.15+11.8%
EPS (basic)-$1.30+63.9%-$3.60+0.0%-$3.60+10.9%-$4.04-28.3%-$3.15+11.8%
Weighted-avg shares (basic)59.8M+3.1%58.0M+2.0%56.9M+5.6%53.9M+11.7%48.3M+23.1%
Weighted-avg shares (diluted)59.8M+3.1%58.0M+2.0%56.9M+5.6%53.9M+11.7%48.3M+23.1%
Balance Sheetas ofSep 30 ’25as ofSep 30 ’24as ofSep 30 ’23as ofSep 30 ’22as ofSep 30 ’21
333M-4.0%347M-18.3%424M-28.9%596M+9.1%546M+63.2%
Cash & equivalents183M-19.1%226M-21.0%286M-24.4%379M-18.7%466M+397.3%
Short-term investments49.4M-1.4%50.1M+0.3%49.9M-60.5%126M+949.4%12.0M-93.9%
Cash & short-term investments——336M-33.4%505M+5.7%478M+64.8%
Accounts receivable57.0M+63.4%34.9M-20.8%44.1M+9.4%40.3M+41.1%28.5M+8.2%
Inventory28.3M+17.6%24.1M-24.9%32.1M-18.4%39.3M+23.6%31.8M+158.8%
Prepaid expenses15.2M+33.4%11.4M-2.7%11.7M-1.7%11.9M+43.8%8.28M+33.5%
Other current assets
1.72M————
642M+4.5%614M-20.9%776M-19.2%961M+36.9%702M+76.0%
Property, plant & equipment102M-0.2%103M-22.2%132M-5.5%139M+216.0%44.1M+73.3%
Operating lease right-of-use49.4M-16.1%58.8M-17.8%71.5M-4.6%74.9M+21.7%61.6M+82.7%
Goodwill82.2M-4.2%85.8M+0.0%85.8M+0.0%85.8M+282.5%22.4M+1871.4%
Intangible assets13.4M-7.3%14.5M-73.4%54.5M-8.8%59.7M+227.1%18.3M+5848.5%
Long-term investments
————0.00
Other non-current assets4.90M+212.6%1.57M-72.4%5.68M+67.8%3.38M-55.9%7.67M+171.8%
91.4M+28.7%71.0M-3.2%73.3M-19.1%90.7M+43.8%63.1M+75.0%
Accounts payable11.1M+580.6%1.63M-88.4%14.1M-30.1%20.1M+34.8%14.9M+208.5%
Accrued liabilities22.8M+51.1%15.1M+40.5%10.8M+5.8%10.2M+58.0%6.44M+65.0%
Deferred revenue6.88M+223.0%2.13M-28.9%3.00M-13.7%3.48M+219.5%1.09M
Short-term & current debt———0.00-100.0%1.55M-53.4%
Current lease liability13.8M-6.6%14.8M-0.6%14.9M+9.2%13.6M+66.1%8.21M+28.1%
Other current liabilities35.2M+505.2%5.82M-25.5%7.80M-60.5%19.7M+105.1%9.62M+268.6%
169M+19.3%142M-7.4%153M-11.1%172M+41.8%121M+93.7%
Deferred revenue (non-current)
0.00————
Non-current lease liability61.8M-12.1%70.2M-11.3%79.2M-2.6%81.3M+52.9%53.2M+114.0%
Operating lease liability (total)75.6M-11.1%85.0M———
Other non-current liabilities747K+83.5%407K-14.3%475K+691.7%60.0K-98.8%5.07M+1343.9%
473M+0.1%473M-24.2%623M-21.0%789M+35.9%581M+72.7%
Common stock0.000.000.000.000.00
Additional paid-in capital1.79B+4.6%1.72B+3.5%1.66B+2.3%1.62B+36.0%1.19B+49.9%
Retained earnings-1.32B-6.3%-1.24B-20.2%-1.03B-24.7%-828M-35.7%-611M-33.2%
Accumulated other comprehensive income-627K-20.1%-522K+31.0%-756K+59.0%-1.84M-437.5%546K+527.6%
Total liabilities & equity642M+4.5%614M-20.9%776M-19.2%961M+36.9%702M+76.0%
Common shares issued60.6M+3.0%58.9M+2.3%57.6M+1.8%56.5M+14.2%49.5M+9.8%
Common shares outstanding60.6M+3.0%58.9M+2.3%57.6M+1.8%56.5M+14.2%49.5M+9.8%
Shares outstanding (cover)61.1M+3.0%59.4M+2.9%57.7M+2.0%56.6M+14.0%49.6M+9.9%
Cash Flowas ofSep 30 ’25as ofSep 30 ’24as ofSep 30 ’23as ofSep 30 ’22as ofSep 30 ’21
-47.6M+25.7%-64.1M+55.0%-142M-14.5%-124M-10.8%-112M+21.1%
Depreciation & amortization24.9M-20.9%31.4M+7.2%29.3M+77.5%16.5M+69.4%9.75M+46.0%
Intangible amortization1.10M-73.2%4.10M-22.6%5.30M+8.2%4.90M+880.0%500K+150.0%
Share-based compensation64.5M+26.6%50.9M+68.2%30.3M-62.0%79.7M+115.3%37.0M+116.4%
Deferred income taxes0.000.000.00+100.0%-11.2M-456.3%-2.01M
Change in receivables22.4M+365.1%-8.44M-295.5%4.32M-55.1%9.62M+337.0%2.20M-84.6%
Change in inventory4.23M+153.0%-7.99M-10.3%-7.24M-196.0%7.54M-61.3%19.5M+293.2%
Change in payables9.33M+179.1%-11.8M-370.7%-2.51M-134.0%7.38M-13.6%8.54M+255.1%
-24.8M-706.3%-3.07M-106.1%50.6M+121.7%-233M-249.2%156M+236.2%
Capital expenditure28.0M+451.7%5.08M-81.7%27.8M-72.7%102M+276.4%27.1M+174.2%
Free cash flow-75.6M-9.3%-69.2M+59.4%-170M+24.7%-226M-62.4%-139M+8.4%
Acquisitions0.000.000.00-100.0%8.16M+1589.4%483K
Purchases of investments49.4M-4.8%51.9M-32.0%76.3M-64.9%218M+270.2%58.8M-71.0%
Sales/maturities of investments50.1M-7.0%53.9M-65.2%155M+54.0%100M-58.6%242M+147.2%
28.5M+314.2%6.89M+656.3%911K-99.7%271M-17.8%329M+8.4%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.00-100.0%1.56M-53.3%3.33M+0.0%
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
FX effect on cash143K+13.5%126K+566.7%-27.0K+91.5%-319K-1695.0%20.0K-4.8%
Net change in cash-43.7M+27.3%-60.1M+33.9%-91.0M-4.5%-87.1M-123.3%373M+696.4%
Interest paid—0.000.00-100.0%9.00K-94.6%167K-61.9%
Income taxes paid683K+98.5%344K-18.1%420K+70.7%246K+143.6%101K-41.3%
Source filing10-K10-K10-K10-K/A10-K

About this data

Source: TWST’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TWST filings on SEC EDGAR → Not investment advice.